Loading...
Header Logo
Keywords
Last Name
Institution

Ms Liliana Valderrama

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rosales-Chilama M, Gongora RE, Valderrama L, Jojoa J, Alexander N, Rubiano LC, Cossio A, Adams ER, Saravia NG, Gomez MA. Parasitological Confirmation and Analysis of Leishmania Diversity in Asymptomatic and Subclinical Infection following Resolution of Cutaneous Leishmaniasis. PLoS Negl Trop Dis. 2015 Dec; 9(12):e0004273. PMID: 26659114.
      View in: PubMed
    2. Fernández OL, Diaz-Toro Y, Ovalle C, Valderrama L, Muvdi S, Rodríguez I, Gomez MA, Saravia NG. Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia. PLoS Negl Trop Dis. 2014 May; 8(5):e2871. PMID: 24853871.
      View in: PubMed
    3. Obonaga R, Fernández OL, Valderrama L, Rubiano LC, Castro Mdel M, Barrera MC, Gomez MA, Gore Saravia N. Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species. Antimicrob Agents Chemother. 2014; 58(1):144-52. PMID: 24145529.
      View in: PubMed
    4. Ramírez C, Díaz-Toro Y, Tellez J, Castilho TM, Rojas R, Ettinger NA, Tikhonova I, Alexander ND, Valderrama L, Hager J, Wilson ME, Lin A, Zhao H, Saravia NG, McMahon-Pratt D. Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response. PLoS Negl Trop Dis. 2012; 6(10):e1866. PMID: 23145196.
      View in: PubMed
    5. Fernández O, Diaz-Toro Y, Valderrama L, Ovalle C, Valderrama M, Castillo H, Perez M, Saravia NG. Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp. J Clin Microbiol. 2012 Jul; 50(7):2207-11. PMID: 22518860.
      View in: PubMed
    6. Castilho TM, Goldsmith-Pestana K, Lozano C, Valderrama L, Saravia NG, McMahon-Pratt D. Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease. Eur J Immunol. 2010 Oct; 40(10):2816-29. PMID: 20827674.
      View in: PubMed
    7. Díaz YR, Rojas R, Valderrama L, Saravia NG. T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species. J Infect Dis. 2010 Aug 15; 202(3):406-15. PMID: 20583921.
      View in: PubMed
    8. Goyeneche-Patino DA, Valderrama L, Walker J, Saravia NG. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis. Antimicrob Agents Chemother. 2008 Dec; 52(12):4503-6. PMID: 18824610.
      View in: PubMed
    9. Salazar JC, Cruz AR, Pope CD, Valderrama L, Trujillo R, Saravia NG, Radolf JD. Treponema pallidum elicits innate and adaptive cellular immune responses in skin and blood during secondary syphilis: a flow-cytometric analysis. J Infect Dis. 2007 Mar 15; 195(6):879-87. PMID: 17299719.
      View in: PubMed
    10. Guarín N, Palma GI, Pirmez C, Valderrama L, Tovar R, Saravia NG. Comparative immunohistological analysis of the Montenegro skin test reaction in asymptomatic infection and in acute and chronic cutaneous leishmaniasis. Biomedica. 2006 Oct; 26 Suppl 1:38-48. PMID: 17361840.
      View in: PubMed
    11. Vergel C, Palacios R, Cadena H, Posso CJ, Valderrama L, Perez M, Walker J, Travi BL, Saravia NG. Evidence for leishmania (viannia) parasites in the skin and blood of patients before and after treatment. J Infect Dis. 2006 Aug 15; 194(4):503-11. PMID: 16845635.
      View in: PubMed
    12. Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. J Infect Dis. 2006 May 15; 193(10):1375-83. PMID: 16619185.
      View in: PubMed
    13. Saravia NG, Escorcia B, Osorio Y, Valderrama L, Brooks D, Arteaga L, Coombs G, Mottram J, Travi BL. Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models. Vaccine. 2006 May 08; 24(19):4247-59. PMID: 16216395.
      View in: PubMed
    14. Saravia NG, Hazbón MH, Osorio Y, Valderrama L, Walker J, Santrich C, Cortázar T, Lebowitz JH, Travi BL. Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana. Vaccine. 2005 Jan 11; 23(8):984-95. PMID: 15620471.
      View in: PubMed
    15. Saravia NG, Weigle K, Navas C, Segura I, Valderrama L, Valencia AZ, Escorcia B, McMahon-Pratt D. Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia. Am J Trop Med Hyg. 2002 Jun; 66(6):738-44. PMID: 12224583.
      View in: PubMed
    16. Martínez JE, Valderrama L, Gama V, Leiby DA, Saravia NG. Clonal diversity in the expression and stability of the metastatic capability of Leishmania guyanensis in the golden hamster. J Parasitol. 2000 Aug; 86(4):792-9. PMID: 10958458.
      View in: PubMed
    17. Bosque F, Saravia NG, Valderrama L, Milon G. Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection. Scand J Immunol. 2000 May; 51(5):533-41. PMID: 10792848.
      View in: PubMed
    18. Lenis AM, Blank A, Valderrama L, Saravia NG. Relationship between the human T-lymphotropic virus type 1 infection and clinical manifestations of tegumentary leishmaniasis in the Colombian Pacific Coast. Mem Inst Oswaldo Cruz. 1999 Jan-Feb; 94(1):19-20. PMID: 10029908.
      View in: PubMed
    19. Bosque F, Milon G, Valderrama L, Saravia NG. Permissiveness of human monocytes and monocyte-derived macrophages to infection by promastigotes of Leishmania (Viannia) panamensis. J Parasitol. 1998 Dec; 84(6):1250-6. PMID: 9920322.
      View in: PubMed
    20. Saravia NG, Segura I, Holguin AF, Santrich C, Valderrama L, Ocampo C. Epidemiologic, genetic, and clinical associations among phenotypically distinct populations of Leishmania (Viannia) in Colombia. Am J Trop Med Hyg. 1998 Jul; 59(1):86-94. PMID: 9684634.
      View in: PubMed
    21. Zea AH, Ochoa MT, Ghosh P, Longo DL, Alvord WG, Valderrama L, Falabella R, Harvey LK, Saravia N, Moreno LH, Ochoa AC. Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun. 1998 Feb; 66(2):499-504. PMID: 9453602.
      View in: PubMed
    22. Ochoa MT, Valderrama L, Ochoa A, Zea A, Escobar CE, Moreno LH, Falabella R. Lepromatous and tuberculoid leprosy: clinical presentation and cytokine responses. Int J Dermatol. 1996 Nov; 35(11):786-90. PMID: 8915730.
      View in: PubMed
    23. Pacheco RS, Martinez JE, Valderrama L, Momen H, Saravia NG. Genotypic polymorphisms in experimental metastatic dermal leishmaniasis. Mol Biochem Parasitol. 1995 Feb; 69(2):197-209. PMID: 7770084.
      View in: PubMed
    24. Weigle KA, Santrich C, Martinez F, Valderrama L, Saravia NG. Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations. J Infect Dis. 1993 Sep; 168(3):699-708. PMID: 8354912.
      View in: PubMed
    25. Weigle KA, Santrich C, Martinez F, Valderrama L, Saravia NG. Epidemiology of cutaneous leishmaniasis in Colombia: environmental and behavioral risk factors for infection, clinical manifestations, and pathogenicity. J Infect Dis. 1993 Sep; 168(3):709-14. PMID: 8354913.
      View in: PubMed
    26. Gutierrez Y, Salinas GH, Palma G, Valderrama LB, Santrich CV, Saravia NG. Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection. Am J Trop Med Hyg. 1991 Sep; 45(3):281-9. PMID: 1928562.
      View in: PubMed
    27. Weigle KA, Valderrama L, Arias AL, Santrich C, Saravia NG. Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. Am J Trop Med Hyg. 1991 Mar; 44(3):260-71. PMID: 2035747.
      View in: PubMed
    28. Labrada M, Weigle K, Valderrama L, Saravia NG. [Evaluation of immunoglobin isotype specific to Leishmania in tegumentary American leishmaniasis]. Mem Inst Oswaldo Cruz. 1989 Jul-Sep; 84(3):409-16. PMID: 2520833.
      View in: PubMed
    29. Saravia NG, Valderrama L, Labrada M, Holguín AF, Navas C, Palma G, Weigle KA. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Infect Dis. 1989 Apr; 159(4):725-35. PMID: 2647862.
      View in: PubMed
    30. Salinas G, Valderrama L, Palma G, Montes G, Saravia NG. [Detection of amastigotes in cutaneous and mucocutaneous leishmaniasis using the immunoperoxidase method, using polyclonal antibody: sensibility and specificity compared with conventional methods of diagnosis]. Mem Inst Oswaldo Cruz. 1989 Jan-Mar; 84(1):53-60. PMID: 2181244.
      View in: PubMed
    31. Weigle KA, Valderrama L, Santrich C, Saravia NG. Recurrences of tegumentary leishmaniasis. Lancet. 1985 Sep 07; 2(8454):557-8. PMID: 2863579.
      View in: PubMed
    Valderrama's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description